Viomi Technology . Earnings Calls
| Release date | Jun 24, 2026 |
| EPS estimate | $0.0695 |
| EPS actual | - |
| Revenue estimate | 206.394M |
| Revenue actual | - |
| Expected change | +/- 11.25% |
| Release date | Mar 25, 2026 |
| EPS estimate | $0.0695 |
| EPS actual | $0.0386 |
| EPS Surprise | -44.43% |
| Revenue estimate | 206.394M |
| Revenue actual | 135.899M |
| Revenue Surprise | -34.16% |
| Release date | Nov 10, 2025 |
| EPS estimate | $0.0401 |
| EPS actual | $0.0775 |
| EPS Surprise | 93.34% |
| Revenue estimate | 189.385M |
| Revenue actual | 199.534M |
| Revenue Surprise | 5.36% |
| Release date | Aug 20, 2025 |
| EPS estimate | $0.0201 |
| EPS actual | $0.0401 |
| EPS Surprise | 99.80% |
| Revenue estimate | 131.367M |
| Revenue actual | 189.385M |
| Revenue Surprise | 44.17% |
Last 4 Quarters for Viomi Technology .
Below you can see how VIOT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 20, 2025 |
| Price on release | $3.30 |
| EPS estimate | $0.0201 |
| EPS actual | $0.0401 |
| EPS surprise | 99.80% |
| Date | Price |
|---|---|
| Aug 14, 2025 | $3.73 |
| Aug 15, 2025 | $3.79 |
| Aug 18, 2025 | $3.67 |
| Aug 19, 2025 | $3.31 |
| Aug 20, 2025 | $3.30 |
| Aug 21, 2025 | $3.61 |
| Aug 22, 2025 | $3.67 |
| Aug 25, 2025 | $3.59 |
| Aug 26, 2025 | $3.79 |
| 4 days before | -11.53% |
| 4 days after | 14.85% |
| On release day | 9.39% |
| Change in period | 1.61% |
| Release date | Nov 10, 2025 |
| Price on release | $2.83 |
| EPS estimate | $0.0401 |
| EPS actual | $0.0775 |
| EPS surprise | 93.34% |
| Date | Price |
|---|---|
| Nov 04, 2025 | $2.93 |
| Nov 05, 2025 | $3.09 |
| Nov 06, 2025 | $2.96 |
| Nov 07, 2025 | $3.03 |
| Nov 10, 2025 | $2.83 |
| Nov 11, 2025 | $2.84 |
| Nov 12, 2025 | $2.65 |
| Nov 13, 2025 | $2.56 |
| Nov 14, 2025 | $2.60 |
| 4 days before | -3.41% |
| 4 days after | -8.13% |
| On release day | 0.353% |
| Change in period | -11.26% |
| Release date | Mar 25, 2026 |
| Price on release | $1.23 |
| EPS estimate | $0.0695 |
| EPS actual | $0.0386 |
| EPS surprise | -44.43% |
| Date | Price |
|---|---|
| Mar 19, 2026 | $1.32 |
| Mar 20, 2026 | $1.28 |
| Mar 23, 2026 | $1.34 |
| Mar 24, 2026 | $1.36 |
| Mar 25, 2026 | $1.23 |
| Mar 26, 2026 | $1.08 |
| Mar 27, 2026 | $1.07 |
| Mar 30, 2026 | $1.03 |
| Mar 31, 2026 | $1.11 |
| 4 days before | -6.82% |
| 4 days after | -9.76% |
| On release day | -12.20% |
| Change in period | -15.91% |
| Release date | Jun 24, 2026 |
| Price on release | - |
| EPS estimate | $0.0695 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $0.92 |
| Jun 16, 2026 | $0.90 |
| Jun 17, 2026 | $0.90 |
| Jun 18, 2026 | $0.86 |
| Jun 22, 2026 | $0.85 |
Viomi Technology . Earnings Call Transcript Summary of Q4 2025
Key points for investors: Viomi delivered full-year 2025 revenue of RMB 2.428 billion, up 14.6% year-over-year, with net income attributable to ordinary shareholders of RMB 141.6 million (non-GAAP RMB 155.7 million) and a full-year gross margin of ~25.3%. H2 2025 was weaker (H2 revenue RMB 951M, down 25.9% YoY) mainly due to the phase-down of national subsidies for water purifiers and lower home water system sales; gross margin in H2 improved slightly to 23.5%. Management is prioritizing global expansion (North America, Southeast Asia, Europe), new product launches (countertop, multifunctional dispensers, whole-home nutrition systems), AI-driven water technologies, and brand building/offline channel entry in the U.S. They have started overseas manufacturing capacity (premium production line/gigafactory) and expanded global R&D/patent activity (end of 2025: >1,950 patent filings across 14 jurisdictions). Management expects overseas to be a major growth lever (guidance: triple-digit overseas revenue growth in 2026) while margins should improve over time from a larger share of Viomi-branded sales and recurring consumables. The company declared special dividends and a $20M share repurchase authorization (partial execution: ~1.03M ADS repurchased for ~$2.5M); a further special dividend was announced (USD 0.066 per ADS, aggregated RMB 31M). Balance sheet/liquidity remain healthy (as of 12/31/2025: cash & equivalents RMB 806.6M, restricted cash RMB 164.4M, short-term deposits RMB 258M, short-term investments RMB 82.6M). Key risks: lingering domestic subsidy normalization effects, geopolitical/overseas uncertainties, and near-term margin pressure from increased brand and channel investments.
Sign In
Buy VIOT